India Pharma Outlook Team | Thursday, 09 October 2025
Shukra Pharmaceuticals has made a remarkable step to enter the world of cutting-edge medical technology by obtaining official approval from Meril Healthcare for robotic surgery projects, marking its entry into the booming field of medical robotics and orthopedic solutions.
The permission, which is valid till the end of March 2026, is a milestone in Shukra Pharmaceuticals' strategic journey that enables the company to go beyond the pharmaceutical sector and consolidate its position in the high-tech healthcare segment specially in India.
Robotic-assisted surgeries have been widely accepted all over the world due to their perfection, minimally invasive nature, and quick patient recovery besides this, the move also prepares Shukra Pharmaceuticals for India's easy access to these high-tech surgical interventions.
Meril Healthcare, known for its breakthrough medical devices, is joining forces with Shukra Pharmaceuticals to gear up for this robotic surgery program. The collaboration will likely lead to the arrival of new technologies, boosted medical outcomes, as well as the unlocking of uncharted business potential for the company.
Also Read: Enzene Partners with Virtuosi to Advance Biologics Workforce
In fact, this bold maneuver exemplifies the ambition of Shukra Pharmaceuticals to transcend the boundaries of standard pharmaceutical production and still keep pace with the technologically sophisticated medical solution market.
With the adoption of medical robotics and orthopedic technology, the company plans not just to avail itself of new revenue streams but also to make a mark in healthcare that is set to become the next big thing.
